Frederic Vigneault

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis.

Rhinostics, Inc. is a company that revolutionizes swab-based sample processing workflows worldwide. The company is based in Brookline, MA. The company offers simple and elegant swab solutions that bring efficiencies and cost savings to laboratory workflows. The company's flagship product, the Rhinostic automated nasal swab, is designed to work in an automated workflow and offers a robust and consistent 10x sample throughput increase compared to manual methods. Rhinostics products are registered as class I exempt medical devices with the FDA and may be used for clinical collection upon CLIA validation. The company was founded by Michael Springer and Richard Novak. The CEO is Cheri L. Walker.